Amel Tounsi, PhD
Dr. Tounsi is a scientist with immunology and cellular biology background, experienced in cell therapy development from R&D to clinical phase, business development and company Development strategy. Continuous learning and training on the managerial and entrepreneurial aspect of the biotech industry is her drive.
Dr. Tounsi holds a PhD in Biopharmaceutical Sciences from the University Louis Pasteur. She started her career in Germany at the German Cancer Research center (DKFZ) in 2009, then moved back to Belgium in the cellular therapy field at Celyad and Catalent for 10 years. From 2018 to 2020 she was the COO of TEXERE Biotech, a company developing and running automated production lines for tissue processing in clean rooms.
In 2019, she completed her training with an EMBA from the Solvay business school before joining the biotech investment managers team at the Belgian investment fund Noshaq in 2021.